Caredx to participate in the 43rd annual j.p. morgan healthcare conference

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna) - the transplant company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced that the company will participate in the upcoming 43rd annual j.p. morgan healthcare conference in san francisco. caredx's management is scheduled to present on tuesday, january 14, 2025, at.
CDNA Ratings Summary
CDNA Quant Ranking